FDA Import Refusal AEK-7462726-4/40001/1 — Novartis Pharmaceuticals Corporation

Novartis Pharmaceuticals Corporation — FEI 2210396

The FDA refused shipment AEK-7462726-4/40001/1 from Novartis Pharmaceuticals Corporation (United States) on August 5, 2025. The refused product falls under Drugs and Biologics — VALSARTAN (ANTI-HYPERTENSIVE - PART II). Cited charge: 75 This firm has 5 or more other import refusals on record.